Atlas Trials

Phase IV, a Clinical Trial to Assess Safety and Convenience of the Change From DTG/3TC to BIC/FTC/TAF in People With HIV, Good Virological Control and Neuropsychiatric Vulnerabilities

Clinical trial NCT05549180 · COMPLETED

Trial details

NCT number
NCT05549180
Sponsor
Fundacion SEIMC-GESIDA
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
HIV Infections
Start date
2022-10-06
Primary completion
2024-02-13
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.